Bell Potter valuation, page-17

Dear Treed,

Because my English is poor I will try make point avoiding long sentences

a) the endpoint of the trial WAS NOT take care of the bleeding

b) the end point was dimish the number of fatalities and accelerate the chances of transplant.

c) yes the trial definetevelly failure

d) as a consequence if the price was "priced" with certain chances of income(future) of X amount this amount should be deducted from the Bell expectation

e) yes, if something positive came (like the bleeding results) this one must be re-access and consider

   e1) maybe will have additional costs to came to same stage we are now ( this comment is not mine but Julia from Bell Direct on business channel

   e2) yes its fair add to the price(after deduct item d) the forecast of income such new treatment can promote in terms of income.

Sorry,but I insisted my views this 2 copamnies are absolutely un trustfuill keeping the same valuation. This is ridiculous.

But of course I respect your views.

Sincerelly now I'm thinking,what next ? while no news we will test what ? 1.30 ? 1.19 ? 1.00 ? or 0.70 ?

When will come the exhaustion phase when all people decide stop sell ?

This last Friday shows still plenty people losing confidence and what was 100% rate of success suddenly turn in a big question mark in most of other trials, reamining just the existing ones. For sure that changes the moods of 5 dollars share or 50 dollars share and start talk about 2 dollar share..

Than of course all shine disappear suddenly.

 

Cato